Table 2 Univariate analysis of clinical factors and GPS for overall survival (n = 402)
Patients (%) | mOS months (95% CI) | P-value | |
|---|---|---|---|
Age | |||
<60 | 203 (50.5) | 11.6 (10.1-13.2) | 0.808 |
≥ 60 | 199 (49.5) | 12.0 (9.9-14.1) | |
Gender | |||
Male | 293 (72.9) | 11.7 (10.1-13.3) | 0.952 |
Female | 109 (27.1) | 12.1 (10.6-13.6) | |
Liver Mets | |||
Yes | 125 (31.1) | 11.4 (8.5-14.3) | 0.352 |
No | 277 (68.9) | 12.0 (10.7-13.3) | |
Peritoneal Mets | |||
Yes | 159 (39.6) | 9.9 (8.4-11.5) | 0.023 |
No | 243 (60.4) | 13.0 (11.2-14.8) | |
Bone Mets | |||
Yes | 28 (7.0) | 8.2 (7.1-9.3) | 0.117 |
No | 374 (93.0) | 12.1 (10.9-13.2) | |
Albumin | |||
<3.5 | 77 (19.2) | 7.7 (5.9-9.5) | 0.001 |
≥ 3.5 | 325 (80.8) | 12.4 (10.7-14.2) | |
CRP | |||
≤ 1 | 262 (64.9) | 14.8 (12.7-17.0) | 0.001 |
>1 | 140 (34.8) | 8.7 (7.3-10.2) | |
ECOG PS | |||
0-1 | 329 (81.8) | 12.4 (10.9-13.8) | 0.003 |
≥ 2 | 73 (48.2) | 8.7 (7.3-10.0) | |
GPS | |||
0 | 238 (59.2) | 15.3 (13.1-17.5) | 0.001 |
1 | 111 (27.6) | 8.9 (7.2-10.7) | |
2 | 53 (13.2) | 7.6 (4.9-10.2) | |